Live News EQUITY FLASH L impact Oct 26, 2026, 10:53 PM UTC Adaptive Biotechnologies COO Julie Rubinstein Reports $897,456.68 Share Sale President and COO Julie Rubinstein reports selling $897,456.68 in common shares. ADPT SquawkNews Desk